Global Influenza Diagnostics Market by Test Type (Traditional Diagnostic Tests (RIDT, Viral Culture, DFA, and Serological Assays), Molecular Diagnostic Tests(RT-PCR, Isothermal Nucleic Acid Amplification Tests and Others) and Others), By End-User (Hospital, Clinical Laboratories , Research Centers and Point Of Care Testing Centers), and By Region (North America, Europe, Asia Pacific, South America, and Middle East & Africa)

Global Influenza Diagnostics Market
Report Content
1.	Research Strategic Development
1.1.	Market Modelling
1.2.	Product Analysis
1.3.	Market Trend and Economic Factors Analysis
1.4.	Market Segmental Analysis
1.5.	Geographical Mapping
1.6.	Country Wise Segregation
2.	Research Methodology
2.1.	Identification of Target Market
2.2.	Data Acquisition 
2.3.	Refining of Data/ Data Transformations
2.4.	Data Validation through Primary Techniques
2.5.	Exploratory Data Analysis
2.6.	Graphical Techniques/Analysis
2.7.	Quantitative Techniques/Analysis
2.8.	Visual Result/Presentation 
3.	Executive Summary
4.	Market Insights
4.1.	Economic Factor Analysis 
4.1.1.	Drivers
4.1.2.	Trends
4.1.3.	Opportunities
4.1.4.	Challenges
4.2.	Technological Landscape
4.3.	Competitors & Product Analysis
4.4.	Regulatory Framework
4.5.	Company market share analysis, 2019
4.6.	Porter's Five forces analysis
4.7.	New Investment Analysis
4.8.	PESTEL Analysis
5.	Global Influenza Diagnostics Market Overview
5.1.	Market Size & Forecast, 2016-2027
5.1.1.	Demand
5.1.1.1.	By Value (USD Million)
5.2.	Market Share & Forecast, 2016-2027
5.2.1.	By Test Type
5.2.1.1.	Traditional Diagnostic Tests
5.2.1.1.1.	RIDT
5.2.1.1.2.	Viral Culture
5.2.1.1.3.	DFA
5.2.1.1.4.	Serological Assays
5.2.1.2.	Molecular Diagnostic Tests
5.2.1.2.1.	RT-PCR
5.2.1.2.2.	Isothermal Nucleic Acid Amplification Tests
5.2.1.2.3.	Others
5.2.1.3.	Others
5.2.2.	By End-Users
5.2.2.1.	Hospital
5.2.2.2.	Clinical Laboratories
5.2.2.3.	Research Centers
5.2.2.4.	Point Of Care Testing Centers
5.2.3.	By Region
5.2.3.1.	North America
5.2.3.2.	Europe
5.2.3.3.	Asia Pacific
5.2.3.4.	South America 
5.2.3.5.	Middle East & Africa 
6.	North America Influenza Diagnostics Market Overview
6.1.	North America Influenza Diagnostics Market Size & Forecast, 2016-2027
6.1.1.	Demand
6.1.1.1.	By Value (USD Million)
6.2.	North America Influenza Diagnostics Market Share & Forecast, 2016-2027
6.2.1.	By Test Type
6.2.1.1.	Traditional Diagnostic Tests
6.2.1.1.1.	RIDT
6.2.1.1.2.	Viral Culture
6.2.1.1.3.	DFA
6.2.1.1.4.	Serological Assays
6.2.1.2.	Molecular Diagnostic Tests
6.2.1.2.1.	RT-PCR
6.2.1.2.2.	Isothermal Nucleic Acid Amplification Tests
6.2.1.2.3.	Others
6.2.1.3.	Others
6.2.2.	By End-User
6.2.2.1.	Hospital
6.2.2.2.	Clinical Laboratories
6.2.2.3.	Research Centers
6.2.2.4.	Point Of Care Testing Centers
6.2.3.	By Country
6.2.3.1.	US
6.2.3.2.	Canada
6.2.3.3.	Mexico
6.2.4.	Price-Point Analysis
6.2.5.	Manufacturer & Distributor List (Top 5)
6.2.6.	Company Market Share (Top 3-5)
6.2.7.	Economic Impact Study on North America Influenza Diagnostics Market 
7.	Europe Influenza Diagnostics Market Overview
7.1.	Europe Influenza Diagnostics Market Size & Forecast, 2016-2027
7.1.1.	Demand
7.1.1.1.	By Value (USD Million)
7.2.	Europe Influenza Diagnostics Market Share & Forecast, 2016-2027
7.2.1.	By Test Type
7.2.1.1.	Traditional Diagnostic Tests
7.2.1.1.1.	RIDT
7.2.1.1.2.	Viral Culture
7.2.1.1.3.	DFA
7.2.1.1.4.	Serological Assays
7.2.1.2.	Molecular Diagnostic Tests
7.2.1.2.1.	RT-PCR
7.2.1.2.2.	Isothermal Nucleic Acid Amplification Tests
7.2.1.2.3.	Others
7.2.1.3.	Others
7.2.2.	By End-User
7.2.2.1.	Hospital
7.2.2.2.	Clinical Laboratories
7.2.2.3.	Research Centers
7.2.2.4.	Point Of Care Testing Centers
7.2.3.	By Country
7.2.3.1.	Germany
7.2.3.2.	UK
7.2.3.3.	France
7.2.3.4.	Italy
7.2.3.5.	Rest of Europe
7.2.4.	Price-Point Analysis
7.2.5.	Manufacturer & Distributor List (Top 5)
7.2.6.	Company Market Share (Top 3-5)
7.2.7.	Economic Impact Study on Europe Influenza Diagnostics Market 
8.	Asia Pacific Influenza Diagnostics Market Overview
8.1.	Asia Pacific Influenza Diagnostics Market Size & Forecast, 2016-2027
8.1.1.	Demand
8.1.1.1.	By Value (USD Million)
8.2.	Asia Pacific Influenza Diagnostics Market Share & Forecast, 2016-2027
8.2.1.	By Test Type
8.2.1.1.	Traditional Diagnostic Tests
8.2.1.1.1.	RIDT
8.2.1.1.2.	Viral Culture
8.2.1.1.3.	DFA
8.2.1.1.4.	Serological Assays
8.2.1.2.	Molecular Diagnostic Tests
8.2.1.2.1.	RT-PCR
8.2.1.2.2.	Isothermal Nucleic Acid Amplification Tests
8.2.1.2.3.	Others
8.2.1.3.	Others
8.2.2.	By End-User
8.2.2.1.	Hospital
8.2.2.2.	Clinical Laboratories
8.2.2.3.	Research Centers
8.2.2.4.	Point Of Care Testing Centers
8.2.3.	By Country
8.2.3.1.	China
8.2.3.2.	India
8.2.3.3.	Japan
8.2.3.4.	Australia
8.2.3.5.	Rest of Asia Pacific
8.2.4.	Price-Point Analysis
8.2.5.	Manufacturer & Distributor List (Top 5)
8.2.6.	Company Market Share (Top 3-5)
8.2.7.	Economic Impact Study on Asia Pacific Influenza Diagnostics Market 
9.	South America Influenza Diagnostics Market Overview
9.1.	South America Influenza Diagnostics Market Size & Forecast, 2016-2027
9.1.1.	Demand
9.1.1.1.	By Value (USD Million)
9.2.	South America Influenza Diagnostics Market Share & Forecast, 2016-2027
9.2.1.	By Test Type
9.2.1.1.	Traditional Diagnostic Tests
9.2.1.1.1.	RIDT
9.2.1.1.2.	Viral Culture
9.2.1.1.3.	DFA
9.2.1.1.4.	Serological Assays
9.2.1.2.	Molecular Diagnostic Tests
9.2.1.2.1.	RT-PCR
9.2.1.2.2.	Isothermal Nucleic Acid Amplification Tests
9.2.1.2.3.	Others
9.2.1.3.	Others
9.2.2.	By End-User
9.2.2.1.	Hospital
9.2.2.2.	Clinical Laboratories
9.2.2.3.	Research Centers
9.2.2.4.	Point Of Care Testing Centers
9.2.3.	By Country
9.2.3.1.	Brazil
9.2.3.2.	Argentina
9.2.3.3.	Rest of South America
9.2.4.	Price-Point Analysis
9.2.5.	Manufacturer & Distributor List (Top 5)
9.2.6.	Company Market Share (Top 3-5)
9.2.7.	Economic Impact Study on South America Influenza Diagnostics Market
10.	Middle East & Africa Influenza Diagnostics Market Overview
10.1.	Middle East & Africa Influenza Diagnostics Market Size & Forecast, 2016-2027
10.1.1.	Demand
10.1.1.1.	By Value (USD Million)
10.2.	Middle East & Africa Influenza Diagnostics Market Share & Forecast, 2016-2027
10.2.1.	By Test Type
10.2.1.1.	Traditional Diagnostic Tests
10.2.1.1.1.	RIDT
10.2.1.1.2.	Viral Culture
10.2.1.1.3.	DFA
10.2.1.1.4.	Serological Assays
10.2.1.2.	Molecular Diagnostic Tests
10.2.1.2.1.	RT-PCR
10.2.1.2.2.	Isothermal Nucleic Acid Amplification Tests
10.2.1.2.3.	Others
10.2.1.3.	Others
10.2.2.	By End-User
10.2.2.1.	Hospital
10.2.2.2.	Clinical Laboratories
10.2.2.3.	Research Centers
10.2.2.4.	Point Of Care Testing Centers
10.2.3.	By Country
10.2.3.1.	Saudi Arabia
10.2.3.2.	UAE
10.2.3.3.	South Africa
10.2.3.4.	Rest of Middle East & Africa
10.2.4.	Price-Point Analysis
10.2.5.	Manufacturer & Distributor List (Top 5)
10.2.6.	Company Market Share (Top 3-5)
10.2.7.	Economic Impact Study on Middle East & Africa Influenza Diagnostics Market
11.	Competitor Analysis
11.1.	Company Description
11.2.	Financial Analysis
11.3.	Key Products
11.4.	Key Management Personnel 
11.5.	Contact Address
11.6.	SWOT Analysis
11.7.	Company Profile
11.7.1.	F. Hoffmann-La Roche AG
11.7.2.	Quidel Corporation
11.7.3.	Thermo Fisher Scientific
11.7.4.	Abbott Laboratories
11.7.5.	Hologic
11.7.6.	Becton
11.7.7.	Dickinson, and Company
11.7.8.	DiaSorin S.p.A
11.7.9.	Luminex Corporation
11.7.10.	Meridian Bioscience
11.7.11.	GenMark Diagnostics
11.7.12.	SA Scientific
11.7.13.	Sekisui Diagnostics
11.7.14.	bioMérieux SA
11.7.15.	Danaher Corporation
11.7.16.	Siemens Healthineers
11.7.17.	Tecan Trading AG
11.7.18.	ELITech 
11.7.19.	Mast Group,
11.7.20.	Other Prominent Players